Navigation Links
CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
Date:5/15/2008

BOSTON, May 15 /PRNewswire/ -- CenterWatch, a publishing and information services company focused on market research about clinical trials, finds that investigative sites are required to learn multiple EDC (electronic data capture) systems. More than 75% of respondents to a recent CenterWatch survey indicated that they had been trained on three or more EDC systems. In addition, a majority indicated that the effectiveness of their EDC training had improved.

State of the Clinical Trials Industry 2008 is a comprehensive resource that examines all aspects of the clinical trials industry based on proprietary research conducted by CenterWatch and resulting from analyses of industry surveys, physician and patient surveys; and surveys of investigative sites both in the U.S. and overseas. Data and research are presented on the following topics:

-- Site perception of sponsors and CROs globally

-- EDC uptake and usage

-- Patient experience in clinical trials

-- Major causes of trial delays and costs

-- Investigator concerns about trial conduct

-- Industry data on sales and market size

-- Worldwide regulatory submissions and approvals

"Each year researchers, biotech and pharmaceutical executives, CRO executives and investment analysts anticipate the release of the new edition of State of Clinical Trial Industry. It is a key resource that helps them track changes and understand key trends with analysis and insight into the global challenges in the industry," said Mary Jo Lamberti, PhD, Director of Market Research for CenterWatch.

State of the Clinical Trials Industry 2008 contains over 600 charts, graphs, and tables, a review of the top clinical research stories of 2007 as reported by the editorial staff of the CenterWatch newsletters; as well as drug pipeline information and updates on specific disease areas. Much of the data is based on CenterWatch's proprietary clinical research benchmarking surveys that represent global analysis of current sponsor and CRO practices. The 2008 edition features more than 90 completely new charts analyzing the clinical research industry along with updates for hundreds of charts and tables that have become a requirement for industry executives, market researchers, and analysts.

To purchase your copy of State of the Clinical Trials Industry 2008 at the introductory rate of $549 (+ s/h), regular $699 (Special offer of $549 through May 30). Call us at 800-765-9647 or visit our online bookstore at http://www.centerwatch.com.

Corporate licenses are available. For more information, contact us at sales@centerwatch.com or 866-219-3440, ext. 4.

About CenterWatch

Founded in 1994, CenterWatch is a trusted source and global destination for clinical trials information for professionals and patients. A Boston-based publishing and information services company focusing on the clinical research industry, CenterWatch is a business of Jobson Medical Information, LLC. CenterWatch provides proprietary data and information about clinical trials through a variety of publications, databases and information services used by pharmaceutical and biotech companies, CROs, SMOs and investigative sites involved in all aspects of clinical trials.

As a pioneer in publishing clinical trials information, CenterWatch was the first Internet site to publish information about active clinical trials that could be accessed by patients and their advocates. Today, CenterWatch has one of the largest databases of clinical trials actively recruiting patients on the Internet. For more information about CenterWatch's publications and services, please visit http://www.centerwatch.com.


'/>"/>
SOURCE CenterWatch
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Rapid Growth of Asia-Pacific Clinical Trials Market Focus of New CenterWatch Report
2. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
3. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
4. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
5. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
6. Immunosyn Corporation Releases SF-1019 Study Results
7. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
8. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
9. CEL-SCI Corporation Releases Letter to Shareholders
10. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
11. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2017)... , June 9, 2017 More than 400 ... effort to help spread lessons learned from clinical research ... Diabetes Federation (IDF) and Eli Lilly and Company (NYSE: ... second phase of the Bringing Research in Diabetes to ... commitment to helping people with diabetes effectively manage their ...
(Date:6/7/2017)... , June 7, 2017  Novavax, Inc., (Nasdaq: ... of two Phase 2 trials of its RSV F protein ... child bearing age have been published in the journal ... have been shared in prior scientific conferences). The Company previously ... April 2014. Novavax is developing the RSV F Vaccine with ...
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq: ... care, today announced new findings demonstrating positive biochemical outcomes ... System One™. The data will be presented at ... Madrid, Spain . ... Improve Home Dialysis Network in Europe ...
Breaking Medicine Technology:
(Date:6/28/2017)... ... June 28, 2017 , ... The Dianne Michael Insurance ... Cincinnati metropolitan area, is teaming up with the local chapter of the Ronald ... treatment in nearby hospitals. , Ronald McDonald House of Greater Cincinnati, one of ...
(Date:6/27/2017)... ... June 27, 2017 , ... Harbour , a DAO (decentralized ... the Ethereum blockchain, has released their technical specifications . , 2017 has seen ... little systematic approach for determining which offerings will garner the greatest ROI. Dean Eigenmann, ...
(Date:6/27/2017)... ... June 27, 2017 , ... From June 20-22, EarQ and Widex ... Syracuse, New York, where EarQ is headquartered. , Together, the organizations educate hearing ... today’s savvy consumer, and the latest in hearing technology. At the event, EarQ ...
(Date:6/27/2017)... ... June 27, 2017 , ... ... contribute to an upcoming case studies guidebook. This guidebook offers an excellent branding ... book will include articles, case studies and how-to’s that fall into the following ...
(Date:6/27/2017)... ... June 27, 2017 , ... Hammer Strength, the world’s leading ... named Javair Gillett of the Houston Rockets the NBSCA Strength & Conditioning Coach of ... decided by NBSCA members who vote to select the coach who embodies the highest ...
Breaking Medicine News(10 mins):